please select
AMS BioteQ's products go international, providing immediate relief for post-war reconstruction in Ukraine.(圖)
The "Connecting with Ukraine" economic revitalization forum, organized by the Japan International Cooperation Agency (JICA), was held from February 15th to 17th, 2024. It brought together businesses, manufacturers, and research institutions from Japan and Ukraine to contribute to the post-war reconstruction efforts in Ukraine.
AMS BioteQ Unveils Breakthrough in Dressing Innovation, Redefining Medical Materials(圖)
On January 18th, AMS BioteQ (TPE: 6864) announced the successful approval of its application for a novel invention patent in Taiwan titled “ARTIFICIAL DRESSING AND USE OF ARTIFICIAL DRESSING FOR PROMOTING WOUND” by the Intellectual Property Office of the Ministry of Economic Affairs, R.O.C.
AMS BioteQ has achieved significant progress in the global wound dressing market by successfully obtaining U.S. FDA approval.(圖)
AMS BioteQ (TPE: 6864) announced on 11th Dec. last year that its innovative medical care product, "SIPSIP Foam," the wound dressing made of its patented bioengineering technology ExtrO, has successfully obtained the registration number issued by the U.S. FDA.
AMS BioteQ Wound Dressing Approved, Expanding into Innovative Medical Care Market(圖)
AMS BioteQ (stock code: 6864), a leading biotechnology company, announced on the 21st that its innovative medical care material, "SIPSIP Foam Yuanzhang Cotton Wound Dressing," has successfully obtained approval from the Taiwan Food and Drug Administration (TFDA), with a medical device approval permit number.
Outbreak of Dengue Fever: AMS BioteQ Develops Small Molecule Drugs(圖)
In southern Taiwan, there is a significant outbreak of Dengue fever, with the number of infections surpassing thousands of cases this year, reaching a new high for the same period in the past ten years according to statistics from the Centers for Disease Control (CDC). In order to overcome the challenges in treating De
#GO 2023 Medical Japan Tokyo Exclusive Interview(圖)
GeneOnline had an exclusive interview with Taiwan’s 元樟生技 AMS BioteQ at the #2023_Medical_Japan_Tokyo.
AMS BioteQ Debuts in Medical Japan Tokyo 2023: Expanding into New Healthcare Markets(圖)
Medical Japan Tokyo was held grandly from October 11 to 13, gathering medical professionals, manufacturers, medical institutions and research units from around the world. AMS BioteQ Co., Ltd. made its first appearance in the exhibition and became one of the spotlight.
Breaking Boundaries in Wound Care, AMS BioteQ at Medical Japan 2023(圖)
AMS BioteQ: Pioneering Innovation in Antibiotics and Advanced Dressings
Since its establishment in 2018, AMS BioteQ, headquartered in Taiwan, has dedicated itself to the development of cutting-edge antibiotics and antimicrobial dressings.
Breaking Through the Dengue Fever Treatment(圖)
Despite the ongoing prevalence of dengue fever in Taiwan, the primary method of epidemic prevention in our country still relies on traditional mosquito spray.
A New Star in Dengue Fever Treatment? AMS BioteQ Starts with Small Molecule Drugs(圖)
AMS BioteQ collaborates with Professor Sheng-Fan Wang, Director of the Center for Tropical Medicine and Infectious Diseases Research at Kaohsiung Medical University
AMS BioteQ: A New Force in Taiwan's Fight Against Avian Influenza(圖)
As the prices of eggs and chicken soar, avian influenza is posing a significant challenge to human society. The virus, which used to be limited to birds, has recently been reported to infect humans.
Another Breakthrough in Epidemic Prevention!(圖)
Another Breakthrough in Epidemic Prevention! The Team at Kaohsiung Medical University Has Developed a COVID-19 Antibody Testing Platform for Precise Assessment of Antibody Efficacy